Striatal H3K27 Acetylation Linked to Glutamatergic Gene Dysregulation in Human Heroin Abusers Holds Promise as Therapeutic Target

dc.contributor.author	Egervari, Gabor
dc.contributor.author	Landry, Joseph
dc.contributor.author	Callens, James
dc.contributor.author	Fullard, John F.
dc.contributor.author	Roussos, Panos
dc.contributor.author	Keller, Éva
dc.contributor.author	Hurd, Yasmin L
dc.date.accessioned	2022-04-26T09:31:21Z
dc.date.available	2022-04-26T09:31:21Z
dc.date.issued	2017
dc.identifier.citation	pagination=585-594; journalVolume=81; journalIssueNumber=7; journalTitle=BIOLOGICAL PSYCHIATRY;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/4954
dc.identifier.uri	doi:10.1016/j.biopsych.2016.09.015
dc.relation.ispartof	urn:issn:0006-3223
dc.title	Striatal H3K27 Acetylation Linked to Glutamatergic Gene Dysregulation in Human Heroin Abusers Holds Promise as Therapeutic Target
dc.type	Journal Article
dc.date.updated	2018-02-21T13:37:52Z
dc.language.rfc3066	en
dc.identifier.mtmt	3125132
dc.identifier.wos	000397300500013
dc.identifier.scopus	85006818059
dc.identifier.pubmed	27863698